 Economic Times | India rejects AstraZeneca patent appeal on Iressa PharmaTimes The case is the latest stand-off between India and pharma. Last month, Pfizer said it would appeal after the patent on its kidney and liver cancer drug Sutent (sunitinib) was revoked, while Bayer is currently trying to overturn a compulsory licence ... Natco Pharma hits record high after IPAB dismisses AstraZeneca drug appeal Patents appeal board rejects AstraZeneca's plea on cancer drug India rejects AstraZeneca patent appeal |
